Assessing and measuring cognitive function in major depressive disorder

Evidence-Based Mental Health

Volumn 19, Issue 4, 2016, Pages 106-109

  Ragguett, Renee Marie ^a   Cha, Danielle S ^a,b   Kakar, Ron ^a   Rosenblat, Joshua D ^a,c   Lee, Yena ^a   McIntyre, Roger S ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE DEFECT; HUMAN; MAJOR DEPRESSION; MASS SCREENING; MOBILE APPLICATION; PROCEDURES; PSYCHOLOGIC TEST; PSYCHOLOGY;

COGNITIVE DYSFUNCTION; DEPRESSIVE DISORDER, MAJOR; HUMANS; MASS SCREENING; MOBILE APPLICATIONS; PSYCHOLOGICAL TESTS;

EID: 84991818011     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/eb-2016-102456     Document Type: Review

References (38)

1. Kessler RC, Petukhova M, Sampson NA, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012; 21: 169–84.
2. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 743–800.
3. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003; 64: 1465–75.
4. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54: 405–18.
5. Jaeger J, Berns S, Uzelac S, et al. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res 2006; 145: 39–48.
6. Kouvonen A, Oksanen T, Vahtera J, et al. Low workplace social capital as a predictor of depression: the Finnish Public Sector Study. Am J Epidemiol 2008; 167: 1143–51.
7. Rugulies R, Bültmann U, Aust B, et al. Psychosocial work environment and incidence of severe depressive symptoms: prospective findings from a 5-year follow-up of the Danish work environment cohort study. Am J Epidemiol 2006; 163: 877–87.
8. Gonda X, Pompili M, Serafini G, et al. The role of cognitive dysfunction in the symptoms and remission from depression. Ann Gen Psychiatry 2015; 14: 27.
9. McIntyre RS, Lee Y, Mansur RB. Treating to target in major depressive disorder: response to remission to functional recovery. CNS Spectr 2015; 20 (Suppl 1): 20–30; quiz 31.
10. Insel TR. The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry. Am J Psychiatry 2014; 171: 395–7.
11. Hammar A, Ardal G. Cognitive functioning in major depression—a summary. Front Hum Neurosci 2009; 3: 26.
12. Roiser JP, Sahakian BJ. Hot and cold cognition in depression. CNS Spectr 2013; 18: 139–49.
13. Buist-Bouwman MA, Ormel J, de Graaf R, et al. Mediators of the association between depression and role functioning. Acta Psychiatr Scand 2008; 118: 451–8.
14. McIntyre RS, O’Donovan C. The human cost of not achieving full remission in depression. Can J Psychiatry 2004; 49 (Suppl 1): 10S–6S.
15. McIntyre RS, Soczynska JZ, Woldeyohannes HO, et al. The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project. Compr Psychiatry 2015; 56: 279–82.
16. Gelenberg AJ. Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practice. J Clin Psychiatry 2010; 71 (Suppl E1): e01.
17. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006; 367: 1262–70.
18. McIntyre RS, Cha DS, Soczynska JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety 2013; 30: 515–27.
19. Franco-Marina F, Garcia-González JJ, Wagner-Echeagaray F, et al. The Mini-mental State Examination revisited: ceiling and floor effects after score adjustment for educational level in an aging Mexican population. Int Psychogeriatr 2010; 22: 72–81.
20. Rajji TK, Miranda D, Mulsant BH, et al. The MMSE is not an adequate screening cognitive instrument in studies of late-life depression. J Psychiatr Res 2009; 43: 464–70.
21. Bakkour N, Samp J, Akhras K, et al. Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder. Psychiatry Res 2014; 216: 291–302.
22. Russo M, Mahon K, Burdick KE. Measuring cognitive function in MDD: emerging assessment tools. Depress Anxiety 2015; 32: 262–9.
23. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–13.
24. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–9.
25. McIntyre RS, Konarski JZ, Mancini DA, et al. Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ 2005; 173: 1327–34.
26. Svendsen AM, Kessing LV, Munkholm K, et al. Is there an association between subjective and objective measures of cognitive function in patients with affective disorders? Nord J Psychiatry 2012; 66: 248–53.
27. Bora E, Harrison BJ, Yücel M, et al. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 2013; 43: 2017–26.
28. Bortolato B, Carvalho AF, McIntyre RS. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord Drug Targets 2014; 13: 1804–18.
29. Lee RS, Hermens DF, Porter MA, et al. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord 2012; 140: 113–24.
30. Marazziti D, Consoli G, Picchetti M, et al. Cognitive impairment in major depression. Eur J Pharmacol 2010; 626: 83–6.
31. Rosenblat JD, Kakar R, McIntyre RS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol 2015; 19: pyv082.
32. Geldmacher DS, Levin BE, Wright CB. Characterizing healthy samples for studies of human cognitive aging. Front Aging Neurosci 2012; 4: 23.
33. Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol 2006; 21: 623–43.
34. Maruff P, Lim YY, Darby D, et al. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease. BMC Psychol 2013; 1: 30.
35. Morrison GE, Simone CM, Ng NF, et al. Reliability and validity of the NeuroCognitive Performance Test, a web-based neuropsychological assessment. Front Psychol 2015; 6: 1652.
36. Lim J, Oh IK, Han C, et al. Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis. Int Psychogeriatr 2013; 25: 1543–57.
37. Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull 2013; 139: 81–132.
38. Fredrickson J, Maruff P, Woodward M, et al. Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies. Neuroepidemiology 2010; 34: 65–75.